“…Here, we have investigated possible interfaces in DOR homodimeric complexes by means of an integrated experimental−computational approach aimed at selecting energetically favorable dimeric models among all different possibilities amenable to TM4 or TM5 helices. Our focus on these helices was based on a large body of literature suggesting a direct primary involvement of lipid-exposed surfaces of TM4 and/or TM5 in the dimerization/oligomerization interfaces of several GPCRs, in particular: dopamine D2 receptor (D2R) homodimer − , serotonin 5-HT4 receptor homodimer , serotonin 5-HT2C homodimer , α1b-adrenoceptor homodimer , , C5a receptor homodimer , chemokine CCR5 homodimer , serotonin 5-HT2A-metabotropic glutamate receptor 2 heterodimer , secretin , and corticotropin releasing hormone-VT2 arginine vasotocin receptor heterodimer . We performed bioluminescence resonance energy transfer (BRET) experiments to confirm DOR interactions in our experimental system, as well as subsequent cross-linking experiments on DOR constructs with substituted cysteines at the extracellular ends of TM4 and TM5.…”